Recommendations for the reporting of harms in manuscripts on clinical trials assessing osteoarthritis drugs: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) - Honvo, G; Bannuru, RR; Bruyère, O; Rannou, F; Herrero-Beaumont, G; Uebelhart, D; Cooper, C; Arden, N; Conaghan, PG; Reginster, J-Y; Thomas, T; McAlindon, T (Drugs and Aging, 2019)